The Korean Journal of Pain

  • 제28권3호
  • /
  • Pages.167-168
  • /
  • 2015
  • /
  • 2005-9159(pISSN)
  • /
  • 2093-0569(eISSN)
대한통증학회 (The Korean Pain Society)
권호 표지
DOI QR코드

DOI QR Code

Risk Factor and Prevention of Postherpetic Neuralgia

  • Kim, Jae Hun (Department of Anesthesiology and Pain Medicine, Konkuk University Medical Center, Konkuk University School of Medicine)
  • 투고 : 2015.06.16
  • 심사 : 2015.06.16
  • 발행 : 2015.07.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Choi WS, Noh JY, Huh JY, Jo YM, Lee J, Song JY, et al. Disease burden of herpes zoster in Korea. J Clin Virol 2010; 47: 325-9. https://doi.org/10.1016/j.jcv.2010.01.003
  2. Jung HS, Kang JK, Yoo SH. Epidemiological study on the incidence of herpes zoster in the nearby Cheonan. Korean J Pain 2015; 28: 193-7. https://doi.org/10.3344/kjp.2015.28.3.193
  3. Nahm FS, Kim SH, Kim HS, Shin JW, Yoo SH, Yoon MH, et al. Survey on the treatment of postherpetic neuralgia in Korea; multicenter study of 1,414 patients. Korean J Pain 2013; 26: 21-6. https://doi.org/10.3344/kjp.2013.26.1.21
  4. Opstelten W, Zuithoff NP, van Essen GA, van Loon AM, van Wijck AJ, Kalkman CJ, et al. Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study. Pain 2007; 132 Suppl 1: S52-9. https://doi.org/10.1016/j.pain.2007.02.004
  5. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62: 1545-51. https://doi.org/10.1212/01.WNL.0000123261.00004.29
  6. Zaal MJ, Volker-Dieben HJ, D'Amaro J. Risk and prognostic factors of postherpetic neuralgia and focal sensory denervation: a prospective evaluation in acute herpes zoster ophthalmicus. Clin J Pain 2000; 16: 345-51. https://doi.org/10.1097/00002508-200012000-00012
  7. Pica F, Gatti A, Divizia M, Lazzari M, Ciotti M, Sabato AF, et al. One-year follow-up of patients with long-lasting postherpetic neuralgia. BMC Infect Dis 2014; 14: 556. https://doi.org/10.1186/s12879-014-0556-6
  8. Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes zoster and its complications in Germany, 2005-2009. J Infect 2015; 70: 178-86. https://doi.org/10.1016/j.jinf.2014.08.018
  9. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44 Suppl 1: S1-26. https://doi.org/10.1086/510206
  10. Jeon Y. Herpes zoster and postherpetic neuralgia: practical consideration for prevention and treatment. Korean J Pain 2015; 28: 177-84. https://doi.org/10.3344/kjp.2015.28.3.177
  11. Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis 1996; 22: 341-7. https://doi.org/10.1093/clinids/22.2.341
  12. Jackson JL, Gibbons R, Meyer G, Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis. Arch Intern Med 1997; 157: 909-12. https://doi.org/10.1001/archinte.1997.00440290095010
  13. Kumar V, Krone K, Mathieu A. Neuraxial and sympathetic blocks in herpes zoster and postherpetic neuralgia: an appraisal of current evidence. Reg Anesth Pain Med 2004; 29: 454-61.
  14. Kim KH. Herpes zoster vaccination. Korean J Pain 2013; 26: 242-8. https://doi.org/10.3344/kjp.2013.26.3.242
  15. Schmader KE, Levin MJ, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis 2012; 54: 922-8. https://doi.org/10.1093/cid/cir970
  16. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-84. https://doi.org/10.1056/NEJMoa051016